1. Home
  2. DNLI
  3. DNLI News

Latest Denali Therapeutics Inc. (DNLI) News on January 19, 2025

Why Denali Therapeutics (DNLI) Is the Biotech Stock with Biggest Upside Potential
DNLI

Insider Monkey

2 days ago

Why Denali Therapeutics (DNLI) Is the Biotech Stock with Biggest Upside Potential

Denali Therapeutics Announces Key Anticipated 2025 Milestones and Priorities to Further Advance Its Therapeutics Portfolio for Neurodegeneration and Lysosomal Storage Diseases
DNLI

GlobeNewswire

6 days ago

Denali Therapeutics Announces Key Anticipated 2025 Milestones and Priorities to Further Advance Its Therapeutics Portfolio for Neurodegeneration and Lysosomal Storage Diseases

DNLI's Hunter Syndrome Drug Gets Breakthrough Therapy Designation
DNLI

Zacks

10 days ago

DNLI's Hunter Syndrome Drug Gets Breakthrough Therapy Designation

DNLI

MT Newswires

11 days ago

Denali Gets FDA Breakthrough Therapy Designation for Hunter Syndrome Treatment

Denali Therapeutics Announces U.S. FDA Breakthrough Therapy Designation Granted to Tividenofusp Alfa for the Treatment of Hunter Syndrome (MPS II)
DNLI

GlobeNewswire

11 days ago

Denali Therapeutics Announces U.S. FDA Breakthrough Therapy Designation Granted to Tividenofusp Alfa for the Treatment of Hunter Syndrome (MPS II)

Denali Therapeutics price target lowered to $32 from $35 at BTIG
DNLI

TipRanks

11 days ago

Denali Therapeutics price target lowered to $32 from $35 at BTIG

These Stocks Moved the Most Today: Nvidia, Micron, Aurora Innovation, Tesla, Carvana, Moderna, Palantir, and More
DNLI

Barrons.com

11 days ago

These Stocks Moved the Most Today: Nvidia, Micron, Aurora Innovation, Tesla, Carvana, Moderna, Palantir, and More

Denali Reverses Its Fortunes With 'Too Early' Miss In ALS Treatment
DNLI

Investor's Business Daily

11 days ago

Denali Reverses Its Fortunes With 'Too Early' Miss In ALS Treatment

Denali's ALS Study Fails to Meet Primary and Secondary Endpoints
DNLI

Zacks

11 days ago

Denali's ALS Study Fails to Meet Primary and Secondary Endpoints

Denali Therapeutics' Amyotrophic Lateral Sclerosis Misses Pivotal Trial, But Analyst Says It Was Expected
DNLI

Benzinga

12 days ago

Denali Therapeutics' Amyotrophic Lateral Sclerosis Misses Pivotal Trial, But Analyst Says It Was Expected

Denali Therapeutics’ ALS therapy fails to meet primary endpoint in Phase II/III trial
DNLI

Clinical Trials Arena

12 days ago

Denali Therapeutics’ ALS therapy fails to meet primary endpoint in Phase II/III trial

Denali Therapeutics Ratchets Up Losses On Misstep In ALS Treatment. Why The Game Isn't Over Yet.
DNLI

Investor's Business Daily

12 days ago

Denali Therapeutics Ratchets Up Losses On Misstep In ALS Treatment. Why The Game Isn't Over Yet.

These Stocks Are Moving the Most Today: Nvidia, Micron, Uber, Aurora Innovation, Carvana, Moderna, Getty Images, and More
DNLI

Barrons.com

12 days ago

These Stocks Are Moving the Most Today: Nvidia, Micron, Uber, Aurora Innovation, Carvana, Moderna, Getty Images, and More

DNLI

MT Newswires

12 days ago

Baird Initiates Denali Therapeutics at Outperform With $31 Price Target

DNLI

MT Newswires

12 days ago

Denali Therapeutics Trial of Potential ALS Treatment Misses Primary, Secondary Endpoints; Shares Fall After Hours

Denali Therapeutics Announces Topline Results for Regimen G Evaluating eIF2B Agonist DNL343 in the Phase 2/3 HEALEY ALS Platform Trial
DNLI

GlobeNewswire

12 days ago

Denali Therapeutics Announces Topline Results for Regimen G Evaluating eIF2B Agonist DNL343 in the Phase 2/3 HEALEY ALS Platform Trial

Denali Therapeutics Neurodegenerative Disease Platform Sparks Analyst Optimistic
DNLI

Benzinga

16 days ago

Denali Therapeutics Neurodegenerative Disease Platform Sparks Analyst Optimistic

Denali Therapeutics upgraded to Buy from Hold at Stifel
DNLI

TipRanks

a month ago

Denali Therapeutics upgraded to Buy from Hold at Stifel

DNLI

MT Newswires

a month ago

Stifel Nicolaus Upgrades Denali Therapeutics to Buy From Hold, Raises Price Target to $37 From $28

Why Is Denali Therapeutics (DNLI) Down 21.2% Since Last Earnings Report?
DNLI

Zacks

a month ago

Why Is Denali Therapeutics (DNLI) Down 21.2% Since Last Earnings Report?

Denali Starts Dosing in Phase II Parkinson's Disease Study
DNLI

Zacks

a month ago

Denali Starts Dosing in Phase II Parkinson's Disease Study

Denali Therapeutics Announces First Participant Dosed in Phase 2a Study of LRRK2 Inhibitor, BIIB122, in LRRK2-Associated Parkinson’s Disease
DNLI

GlobeNewswire

a month ago

Denali Therapeutics Announces First Participant Dosed in Phase 2a Study of LRRK2 Inhibitor, BIIB122, in LRRK2-Associated Parkinson’s Disease

DNLI

MT Newswires

2 months ago

B. Riley Raises Price Target on Denali Therapeutics to $38 From $33, Keeps Buy Rating

We're Hopeful That Denali Therapeutics (NASDAQ:DNLI) Will Use Its Cash Wisely
DNLI

Simply Wall St.

2 months ago

We're Hopeful That Denali Therapeutics (NASDAQ:DNLI) Will Use Its Cash Wisely

DNLI

MT Newswires

2 months ago

Denali Therapeutics Insider Sold Shares Worth $1,932,665, According to a Recent SEC Filing

Denali Q3 Earnings Miss Estimates, Pipeline Progress Encouraging
DNLI

Zacks

2 months ago

Denali Q3 Earnings Miss Estimates, Pipeline Progress Encouraging

Denali Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights
DNLI

GlobeNewswire

2 months ago

Denali Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights

Analysts Estimate Arcus Biosciences, Inc. (RCUS) to Report a Decline in Earnings: What to Look Out for
DNLI

Zacks

3 months ago

Analysts Estimate Arcus Biosciences, Inc. (RCUS) to Report a Decline in Earnings: What to Look Out for

Denali Therapeutics Inc. (DNLI) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
DNLI

Zacks

3 months ago

Denali Therapeutics Inc. (DNLI) May Report Negative Earnings: Know the Trend Ahead of Q3 Release

DNLI

MT Newswires

3 months ago

Denali Therapeutics Insider Sold Shares Worth $1,107,600, According to a Recent SEC Filing

Denali Therapeutics Inc. (DNLI): Jeff Bezos Is Buying This Stock Now
DNLI

Insider Monkey

3 months ago

Denali Therapeutics Inc. (DNLI): Jeff Bezos Is Buying This Stock Now

Strength Seen in Voyager Therapeutics (VYGR): Can Its 17.5% Jump Turn into More Strength?
DNLI

Zacks

3 months ago

Strength Seen in Voyager Therapeutics (VYGR): Can Its 17.5% Jump Turn into More Strength?

DNLI

MT Newswires

4 months ago

UBS Adjusts Denali Therapeutics Price Target to $46 From $32, Maintains Buy Rating

Strength Seen in Denali Therapeutics (DNLI): Can Its 10.1% Jump Turn into More Strength?
DNLI

Zacks

4 months ago

Strength Seen in Denali Therapeutics (DNLI): Can Its 10.1% Jump Turn into More Strength?

Why Is Kymera Therapeutics (KYMR) Up 10.9% Since Last Earnings Report?
DNLI

Zacks

4 months ago

Why Is Kymera Therapeutics (KYMR) Up 10.9% Since Last Earnings Report?

Myriad (MYGN) Down 4.8% Since Last Earnings Report: Can It Rebound?
DNLI

Zacks

4 months ago

Myriad (MYGN) Down 4.8% Since Last Earnings Report: Can It Rebound?

Denali Plans to File for Accelerated Approval of Hunter Syndrome Drug
DNLI

Zacks

4 months ago

Denali Plans to File for Accelerated Approval of Hunter Syndrome Drug

Why Is BioMarin (BMRN) Up 5.4% Since Last Earnings Report?
DNLI

Zacks

4 months ago

Why Is BioMarin (BMRN) Up 5.4% Since Last Earnings Report?

High-dose Spinraza meets study goal; Top Dyne executives exit
DNLI

BioPharma Dive

4 months ago

High-dose Spinraza meets study goal; Top Dyne executives exit

DNLI

MT Newswires

4 months ago

Wedbush Adjusts Price Target on Denali Therapeutics to $27 From $26, Maintains Outperform Rating

Denali Therapeutics Announces Successful Meeting with the FDA and Plans to File for Accelerated Approval of Tividenofusp Alfa (DNL310) for the Treatment of MPS II (Hunter Syndrome)
DNLI

GlobeNewswire

5 months ago

Denali Therapeutics Announces Successful Meeting with the FDA and Plans to File for Accelerated Approval of Tividenofusp Alfa (DNL310) for the Treatment of MPS II (Hunter Syndrome)

Denali Therapeutics (NASDAQ:DNLI) shareholders are up 3.4% this past week, but still in the red over the last three years
DNLI

Simply Wall St.

5 months ago

Denali Therapeutics (NASDAQ:DNLI) shareholders are up 3.4% this past week, but still in the red over the last three years

DNLI

MT Newswires

5 months ago

Denali Therapeutics Insider Sold Shares Worth $549,928, According to a Recent SEC Filing

Genetic testing in Parkinson’s disease patients: a standard of care imperative?
DNLI

Medical Device Network

5 months ago

Genetic testing in Parkinson’s disease patients: a standard of care imperative?

Denali Therapeutics Announces Publication in Science Translational Medicine Demonstrating the Potential of the Oligonucleotide Transport Vehicle Platform to Achieve Broad Biodistribution of Antisense Oligonucleotides in the CNS and Muscle Following Intravenous Administration
DNLI

GlobeNewswire

5 months ago

Denali Therapeutics Announces Publication in Science Translational Medicine Demonstrating the Potential of the Oligonucleotide Transport Vehicle Platform to Achieve Broad Biodistribution of Antisense Oligonucleotides in the CNS and Muscle Following Intravenous Administration

Wall Street Analysts Believe Denali Therapeutics (DNLI) Could Rally 79.62%: Here's is How to Trade
DNLI

Zacks

5 months ago

Wall Street Analysts Believe Denali Therapeutics (DNLI) Could Rally 79.62%: Here's is How to Trade

DNLI

MT Newswires

5 months ago

B. Riley Adjusts Price Target on Denali Therapeutics to $33 From $36, Maintain Buy Rating

DNLI

MT Newswires

6 months ago

Wedbush Adjusts Denali Therapeutics' PT to $26 From $30, Keeps Outperform Rating

DNLI

MT Newswires

6 months ago

Denali Therapeutics Shares Fall After Swing to Q2 Net Loss

Denali Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights
DNLI

GlobeNewswire

6 months ago

Denali Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights

Denali Therapeutics (DNLI) Stock Jumps 9.7%: Will It Continue to Soar?
DNLI

Zacks

6 months ago

Denali Therapeutics (DNLI) Stock Jumps 9.7%: Will It Continue to Soar?

Denali Therapeutics Stock Gets Technical Rating Upgrade
DNLI

Investor's Business Daily

6 months ago

Denali Therapeutics Stock Gets Technical Rating Upgrade

Denali (DNLI) Outperforms Industry in 3 Months: Here's Why
DNLI

Zacks

7 months ago

Denali (DNLI) Outperforms Industry in 3 Months: Here's Why

Denali Therapeutics (DNLI) Moves 5.8% Higher: Will This Strength Last?
DNLI

Zacks

7 months ago

Denali Therapeutics (DNLI) Moves 5.8% Higher: Will This Strength Last?

Why Is Prothena (PRTA) Down 1.5% Since Last Earnings Report?
DNLI

Zacks

7 months ago

Why Is Prothena (PRTA) Down 1.5% Since Last Earnings Report?

Companies Like Denali Therapeutics (NASDAQ:DNLI) Are In A Position To Invest In Growth
DNLI

Simply Wall St.

7 months ago

Companies Like Denali Therapeutics (NASDAQ:DNLI) Are In A Position To Invest In Growth

Why Is Denali Therapeutics (DNLI) Up 15.6% Since Last Earnings Report?
DNLI

Zacks

7 months ago

Why Is Denali Therapeutics (DNLI) Up 15.6% Since Last Earnings Report?

Denali's (DNLI) Candidate Selected for FDA's START Pilot Program
DNLI

Zacks

7 months ago

Denali's (DNLI) Candidate Selected for FDA's START Pilot Program

DNLI

MT Newswires

8 months ago

Denali Therapeutics' Enzyme Replacement Therapy Picked for FDA's START Pilot Program; Shares Rise

Denali Therapeutics Announces FDA Has Selected DNL126 (ETV:SGSH) for MPS IIIA (Sanfilippo Syndrome Type A) for START Pilot Program Intended to Accelerate Development of Rare Disease Therapies
DNLI

GlobeNewswire

8 months ago

Denali Therapeutics Announces FDA Has Selected DNL126 (ETV:SGSH) for MPS IIIA (Sanfilippo Syndrome Type A) for START Pilot Program Intended to Accelerate Development of Rare Disease Therapies

The Consensus EPS Estimates For Denali Therapeutics Inc. (NASDAQ:DNLI) Just Fell Dramatically
DNLI

Simply Wall St.

8 months ago

The Consensus EPS Estimates For Denali Therapeutics Inc. (NASDAQ:DNLI) Just Fell Dramatically

Denali Therapeutics First Quarter 2024 Earnings: US$0.68 loss per share (vs US$0.80 loss in 1Q 2023)
DNLI

Simply Wall St.

8 months ago

Denali Therapeutics First Quarter 2024 Earnings: US$0.68 loss per share (vs US$0.80 loss in 1Q 2023)

DNLI

MT Newswires

8 months ago

Stifel Adjusts Price Target on Denali Therapeutics to $22 From $26, Maintains Hold Rating

DNLI

MT Newswires

8 months ago

Wedbush Adjusts Denali Therapeutics' Price Target to $30 From $31, Keeps Outperform Rating

Denali (DNLI) Q1 Earnings Miss, Pipeline Progress in Focus
DNLI

Zacks

8 months ago

Denali (DNLI) Q1 Earnings Miss, Pipeline Progress in Focus

DNLI

GuruFocus.com

8 months ago

Denali Therapeutics Q1 2024 Earnings: Misses Revenue Estimates Amid Strategic Shifts

Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
DNLI

GlobeNewswire

8 months ago

Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights

Denali Therapeutics Announces Completion of Enrollment for Regimen G Evaluating eIF2B Agonist DNL343 in the Phase 2/3 HEALEY ALS Platform Trial
DNLI

GlobeNewswire

9 months ago

Denali Therapeutics Announces Completion of Enrollment for Regimen G Evaluating eIF2B Agonist DNL343 in the Phase 2/3 HEALEY ALS Platform Trial

Is There An Opportunity With Denali Therapeutics Inc.'s (NASDAQ:DNLI) 50% Undervaluation?
DNLI

Simply Wall St.

9 months ago

Is There An Opportunity With Denali Therapeutics Inc.'s (NASDAQ:DNLI) 50% Undervaluation?

Why Denali Therapeutics (DNLI) Stock Might be a Great Pick
DNLI

Zacks

9 months ago

Why Denali Therapeutics (DNLI) Stock Might be a Great Pick

Sarepta Therapeutics (SRPT) Up 1.2% Since Last Earnings Report: Can It Continue?
DNLI

Zacks

10 months ago

Sarepta Therapeutics (SRPT) Up 1.2% Since Last Earnings Report: Can It Continue?

Why Is Denali Therapeutics (DNLI) Up 2.8% Since Last Earnings Report?
DNLI

Zacks

10 months ago

Why Is Denali Therapeutics (DNLI) Up 2.8% Since Last Earnings Report?

Further weakness as Denali Therapeutics (NASDAQ:DNLI) drops 7.4% this week, taking three-year losses to 67%
DNLI

Simply Wall St.

10 months ago

Further weakness as Denali Therapeutics (NASDAQ:DNLI) drops 7.4% this week, taking three-year losses to 67%

Denali's (DNLI) Q4 Earnings Miss, Pipeline in Focus, Stock Up
DNLI

Zacks

a year ago

Denali's (DNLI) Q4 Earnings Miss, Pipeline in Focus, Stock Up

Denali Therapeutics Inc (DNLI) Reports Full Year and Q4 2023 Financial Results
DNLI

GuruFocus.com

a year ago

Denali Therapeutics Inc (DNLI) Reports Full Year and Q4 2023 Financial Results

Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
DNLI

GlobeNewswire

a year ago

Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights

Denali Therapeutics Announces $500 million Private Placement Equity Financing
DNLI

GlobeNewswire

a year ago

Denali Therapeutics Announces $500 million Private Placement Equity Financing

Denali, fresh off study setback, gets $500M lift
DNLI

BioPharma Dive

a year ago

Denali, fresh off study setback, gets $500M lift

DNLI

Reuters

a year ago

UPDATE 2-Denali-Sanofi's ALS drug fails to meet mid-stage trial goal

DNLI

Reuters

a year ago

Denali-Sanofi's ALS drug fails to meet main goal of mid-stage trial

ALS drug from Denali, Sanofi falls short in mid-stage study
DNLI

BioPharma Dive

a year ago

ALS drug from Denali, Sanofi falls short in mid-stage study

Denali Therapeutics Announces New Data and Expansion of Its Blood-Brain Barrier (BBB)-Crossing Enzyme Replacement Therapy Programs at WORLDSymposium™
DNLI

GlobeNewswire

a year ago

Denali Therapeutics Announces New Data and Expansion of Its Blood-Brain Barrier (BBB)-Crossing Enzyme Replacement Therapy Programs at WORLDSymposium™

Is Coursera, Inc. (NYSE:COUR) Potentially Undervalued?
DNLI

Simply Wall St.

a year ago

Is Coursera, Inc. (NYSE:COUR) Potentially Undervalued?

Coursera, Inc. (NYSE:COUR) Q4 2023 Earnings Call Transcript
DNLI

Insider Monkey

a year ago

Coursera, Inc. (NYSE:COUR) Q4 2023 Earnings Call Transcript

Newell Brands (NWL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
DNLI

Zacks

a year ago

Newell Brands (NWL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Why Federated Hermes (FHI) is a Top Momentum Stock for the Long-Term
DNLI

Zacks

a year ago

Why Federated Hermes (FHI) is a Top Momentum Stock for the Long-Term

Denali Therapeutics Announces Presentations on Its Investigational Blood-Brain Barrier (BBB)-Crossing Enzyme Replacement Therapies at the Upcoming 2024 WORLDSymposium™
DNLI

GlobeNewswire

a year ago

Denali Therapeutics Announces Presentations on Its Investigational Blood-Brain Barrier (BBB)-Crossing Enzyme Replacement Therapies at the Upcoming 2024 WORLDSymposium™

Baillie Gifford Reduces Stake in Denali Therapeutics Inc
DNLI

GuruFocus.com

a year ago

Baillie Gifford Reduces Stake in Denali Therapeutics Inc

Black Stone Minerals, L.P. Maintains Fourth Quarter Distribution for Common Units and Schedules Earnings Call to Discuss Fourth Quarter and Year-End 2023 Results
DNLI

Business Wire

a year ago

Black Stone Minerals, L.P. Maintains Fourth Quarter Distribution for Common Units and Schedules Earnings Call to Discuss Fourth Quarter and Year-End 2023 Results

Visteon to Announce Fourth Quarter and Full-Year 2023 Results on Feb. 20
DNLI

GlobeNewswire

a year ago

Visteon to Announce Fourth Quarter and Full-Year 2023 Results on Feb. 20

Tri Pointe Homes Named to 2024 List of Fortune World’s Most Admired Companies™
DNLI

GlobeNewswire

a year ago

Tri Pointe Homes Named to 2024 List of Fortune World’s Most Admired Companies™

4 Apparel Stocks That Look Well-Poised for Success in 2024
DNLI

Zacks

a year ago

4 Apparel Stocks That Look Well-Poised for Success in 2024

The Zacks Analyst Blog Highlights American Eagle Outfitters, Deckers Outdoor, Abercrombie & Fitch and The Gap
DNLI

Zacks

a year ago

The Zacks Analyst Blog Highlights American Eagle Outfitters, Deckers Outdoor, Abercrombie & Fitch and The Gap

Kraft Heinz's (KHC) Pricing & Transformation Efforts Solid
DNLI

Zacks

a year ago

Kraft Heinz's (KHC) Pricing & Transformation Efforts Solid

Denali's (DNLI) Pipeline Progresses Despite Stiff Competition
DNLI

Zacks

a year ago

Denali's (DNLI) Pipeline Progresses Despite Stiff Competition

Boston Beer and Huntsman have been highlighted as Zacks Bull and Bear of the Day
DNLI

Zacks

a year ago

Boston Beer and Huntsman have been highlighted as Zacks Bull and Bear of the Day

Valley National Bancorp Full Year 2023 Earnings: EPS Misses Expectations
DNLI

Simply Wall St.

a year ago

Valley National Bancorp Full Year 2023 Earnings: EPS Misses Expectations

Summit Materials Announces Fourth Quarter and Full Year 2023 Results Conference Call Date
DNLI

PR Newswire

a year ago

Summit Materials Announces Fourth Quarter and Full Year 2023 Results Conference Call Date

GATX Corporation (NYSE:GATX) Q4 2023 Earnings Call Transcript
DNLI

Insider Monkey

a year ago

GATX Corporation (NYSE:GATX) Q4 2023 Earnings Call Transcript

Sabra Health Care REIT, Inc. Announces Tax Treatment of 2023 Distributions
DNLI

Business Wire

a year ago

Sabra Health Care REIT, Inc. Announces Tax Treatment of 2023 Distributions

Share on Social Networks: